Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Emily Botto

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Nature Biotechnology|June 14, 2023
What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?Jennifer Y Kim, Emily Botto
Therapeutic Innovation & Regulatory Science|March 26, 2024
New Benchmarks on Protocol Amendment Experience in Oncology Clinical TrialsEmily Botto, Zachary Smith, Kenneth Getz
Therapeutic Innovation & Regulatory Science|June 10, 2022
Quantifying Diversity and Representation in Pivotal Trials Leading to Marketing Authorization in EuropeZachary Smith, Emily Botto, Kenneth Getz
JAMA Network Open|June 7, 2024
Mapping Strategies for Reaching Socioeconomically Disadvantaged Populations in Clinical TrialsMaria I Florez, Emily Botto, Jennifer Y Kim
Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.
JAMA Network Open|May 13, 2025
A Clinical Research Interaction Scale for Racial and Ethnic Minority ParticipantsJennifer Y Kim, Emily Botto, Ruby Madison Ford
Therapeutic Innovation & Regulatory Science|March 4, 2024
New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial PerformanceKenneth Getz, Zachary Smith, Emily Botto, et al.
Therapeutic Innovation & Regulatory Science|September 29, 2023
New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA-Approved Drugs and BiologicsZachary Smith, Emily Botto, Otis Johnson, et al.
Therapeutic Innovation & Regulatory Science|October 16, 2022
Insights from a Multi-company Workshop to Apply a Patient Participation Burden Algorithm to Protocol DataZachary Smith, Emily Botto, Christopher Carney, et al.
Communications Medicine|September 5, 2024
The influence of socioeconomic status on individual attitudes and experience with clinical trialsJennifer Y Kim, Maria Florez, Emily Botto, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Nature Biotechnology|June 14, 2023
What is hindering the drug development industry from achieving diversity, equity and inclusion in its workforce?Jennifer Y Kim, Emily Botto
Therapeutic Innovation & Regulatory Science|March 26, 2024
New Benchmarks on Protocol Amendment Experience in Oncology Clinical TrialsEmily Botto, Zachary Smith, Kenneth Getz
Therapeutic Innovation & Regulatory Science|June 10, 2022
Quantifying Diversity and Representation in Pivotal Trials Leading to Marketing Authorization in EuropeZachary Smith, Emily Botto, Kenneth Getz
JAMA Network Open|June 7, 2024
Mapping Strategies for Reaching Socioeconomically Disadvantaged Populations in Clinical TrialsMaria I Florez, Emily Botto, Jennifer Y Kim
Therapeutic Innovation & Regulatory Science|June 8, 2025
Trends in the Burden for Patients Participating in Industry-Funded Clinical TrialsAbigail Dirks, Emily Botto, Zachary Smith, et al.
JAMA Network Open|May 13, 2025
A Clinical Research Interaction Scale for Racial and Ethnic Minority ParticipantsJennifer Y Kim, Emily Botto, Ruby Madison Ford
Therapeutic Innovation & Regulatory Science|March 4, 2024
New Benchmarks on Protocol Amendment Practices, Trends and their Impact on Clinical Trial PerformanceKenneth Getz, Zachary Smith, Emily Botto, et al.
Therapeutic Innovation & Regulatory Science|September 29, 2023
New Benchmarks on Demographic Disparities in Pivotal Trials Supporting FDA-Approved Drugs and BiologicsZachary Smith, Emily Botto, Otis Johnson, et al.
Therapeutic Innovation & Regulatory Science|October 16, 2022
Insights from a Multi-company Workshop to Apply a Patient Participation Burden Algorithm to Protocol DataZachary Smith, Emily Botto, Christopher Carney, et al.
Communications Medicine|September 5, 2024
The influence of socioeconomic status on individual attitudes and experience with clinical trialsJennifer Y Kim, Maria Florez, Emily Botto, et al.
Pageof 2